Clinical Response of Advanced Lung Adenocarcinoma with Class III BRAF G466V Missense Mutation to Dabrafenib and Trametinib: A Case Report
-
Published:2024-01
Issue:
Volume:Volume 17
Page:27-31
-
ISSN:1178-6930
-
Container-title:OncoTargets and Therapy
-
language:en
-
Short-container-title:OTT
Author:
Fang RuoxinORCID,
Xu Sha,
Gong Jun,
Liao Zhengkai
Publisher
Informa UK Limited